Funding for Researchers

Research grant opportunities

Each spring, we announce new research grant opportunities in neuroendocrine cancer. We encourage investigators from around the world to propose their fresh ideas to study neuroendocrine tumors in innovative ways.

2019 research grant announcement

In 2019, neuroendocrine cancer research grant opportunities will be announced on Thursday, May 16, 2019

To be considered, applicants must submit a competitive letter of intent (LOI) online by Monday, June 17, 2019

Neuroendocrine research grant types

We offer four different neuroendocrine cancer research grants ( Accelerator, Investigator, Pilot, and Mentored Awards) with cancer research grants ranging from $50,0000 to $1.2 million. 

Seeking transformational ideas

We invite innovative and transformative research proposals in NETs to help bring the field closer to more effective therapies. We are equally interested in basic, translational and clinical research applications, and encourage collaborations between investigators with expertise in different fields.

Encouraging team science

We are very interested in grant proposals from multidisciplinary groups comprised of basic scientists, clinicians, and experts in bioinformatics, bio-nanotechnology, or other relevant disciplines. Proposals that cover promising and potentially transferable mechanisms and/or technologies, which have been applied successfully to other areas of cancer research, are highly desirable and will be evaluated based on their level of applicability to NETs.

Learn more about our 2019 research grants.

Areas of interest

Some areas of interest include but not limited to:

  • Application of existing or new technologies to target NETs
  • New/optimized experimental models
  • Cancer metabolism
  • Deciphering the molecular underpinnings of NETs
  • Diagnostics
  • Clinical Research
  • Cell invasion and metastasis
  • Immune microenvironment
  • Nuclear medicine, theranostics, imaging

We invite also proposals that cover promising and potentially transferable technologies, which have been applied successfully to other areas of cancer.

Organs of interest

While we recognize that neuroendocrine cancers can develop in many different organs, we exclusively focus on:

GEP-NETs

We continue to have an interest and fund applications proposing to study all aspects of gastro-entero-pancreatic NETs, including sites of metastasis.

Lung Carcinoids

We are interested in funding work in well-differentiated, low-grade typical carcinoids (TCs), well-differentiated, intermediate-grade atypical carcinoids (ACs), or diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH).

Currently, the lung fund does not extend to SCLC, LCLC, non-SCLC, squamous cell carcinomas, adenocarcinomas, mesotheliomas or poorly differentiated non–small cell lung carcinomas.

Areas for which we do not have specific funds right now, include NETs in organs such as brain, prostate, etc.

Expanding the field

Prior research in NETs is not a prerequisite. We encourage expert cancer scientists to enter the NET research field. However, such candidates must demonstrate a commitment to continue with NET research.

See our FAQ for more information.

Send us a question.

Sign Up

Be notified of grant opportunities